Compounds > bosentan anhydrous
Page last updated: 2024-08-26

bosentan anhydrous and Dermatomyositis

bosentan anhydrous has been researched along with Dermatomyositis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Combalia, A; Giavedoni, P; Grau-Junyent, JM; Mascaró, JM; Tamez, L1

Other Studies

1 other study(ies) available for bosentan anhydrous and Dermatomyositis

ArticleYear
Bosentan for Cutaneous Ulcers in Anti-MDA5 Dermatomyositis.
    JAMA dermatology, 2018, 03-01, Volume: 154, Issue:3

    Topics: Aged; Antihypertensive Agents; Autoantibodies; Bosentan; Dermatomyositis; Female; Humans; Interferon-Induced Helicase, IFIH1; Skin Ulcer

2018